XML 38 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating activities    
Net loss $ (26,293) $ (25,870)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation and amortization 26 119
Stock-based compensation expense 1,512 1,771
Accretion of discount/premium on investment securities 5 (6)
Non-cash interest expense   37
Gain on disposal of property and equipment 18 (297)
Services received in non-monetary exchange 33 19
Changes in assets and liabilities:    
Prepaid expenses and other current assets (1,289) (177)
Other assets   (85)
Right-of-use asset-operating (96)  
Accounts payable (211) 662
Accrued expenses (205) 396
Other liabilities (69) (34)
Net cash used in operating activities (26,569) (23,465)
Investing activities    
Purchases of short-term investments (155,197) (70,364)
Sales and maturities of short-term investments 151,127 48,090
Purchases of property and equipment (12)  
Proceeds from sale of property and equipment   369
Net cash used in investing activities (4,082) (21,905)
Financing activities    
Proceeds from public offerings, net of issuance costs 18,505 38,886
Proceeds from at-the-market offering, net of issuance costs 7,061 8,253
Proceeds from exercise of common stock options and warrants 54 4
Payments on borrowing   (2,848)
Net cash provided by financing activities 25,620 44,295
Net increase in cash, cash equivalents and restricted cash (5,031) (1,075)
Cash, cash equivalents and restricted cash, beginning of period 15,407 16,482
Cash, cash equivalents and restricted cash, end of period 10,376 15,407
Supplemental disclosure of cash flow information    
Cash paid for interest   79
Non-cash investing activities:    
Fixed asset purchases included in accounts payable   18
Non-cash financing activities    
At-the-market issuance costs included in current liabilities $ 65 $ 110